Listen to Amos de Jong about his study on the on facilitators and barriers for DCTs from a regulatory perspective.
Implementation of new innovative approaches in clinical practice are always accompanied by (regulatory) challenges. In the IMI Trials@Home project, we reached out to European ethics committees and asked them to conduct a (mock) review of our decentralised clinical trial approach. The feedback was used to inform design adjustments for the RADIAL trial. Check out this video where Tessa van Rijssel tells more about her project.
In this video, Julia Kopanz talks about her ongoing research into patient preferences for decentralised clinical trial approaches.
Within the IMI Trials@Home project we were curious to know more about the implementation of decentralized trial activities in clinical trials. To learn more, we investigated which and if decentralised and on-site conduct of trial activities were reported in CT protocols with a trial start date in 2019 or 2020.
Interested in our findings? Then check out this video where Renske Grupstra tells more about this project.
In this video our Utrecht University colleague Yared Santa Ana Téllez talks about our recent paper ‘Decentralised, patient-centric, site-less, virtual, and digital clinical trials? From confusion to consensus’, also co-authored by Bart Lagerwaard, Amos de Jong, Helga Gardarsdottir, Diederick (Rick) E. Grobbee, MD, PhD, FESC, Kim Hawkins, Megan Heath.
In this specific project, we interviewed members of European Health Technology Assessment bodies to identify opportunities and challenges of DCTs from an HTA perspective. Check out this video where Nadi Shahid tells more about her project.